SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-028740
Filing Date
2014-05-08
Accepted
2014-05-08 17:22:09
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v376157_10q.htm 10-Q 403910
2 EXHIBIT 31.1 v376157_ex31-1.htm EX-31.1 10039
3 EXHIBIT 31.2 v376157_ex31-2.htm EX-31.2 10532
4 EXHIBIT 32.1 v376157_ex32-1.htm EX-32.1 4158
5 EXHIBIT 32.2 v376157_ex32-2.htm EX-32.2 4578
  Complete submission text file 0001144204-14-028740.txt   4015291

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvax-20140331.xml EX-101.INS 475784
7 XBRL TAXONOMY EXTENSION SCHEMA nvax-20140331.xsd EX-101.SCH 39111
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20140331_cal.xml EX-101.CAL 50656
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20140331_def.xml EX-101.DEF 151862
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20140331_lab.xml EX-101.LAB 599660
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20140331_pre.xml EX-101.PRE 271986
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 14826135
SIC: 2836 Biological Products, (No Diagnostic Substances)